Results 141 to 150 of about 1,716,393 (201)

Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization. [PDF]

Clin Infect Dis, 2018
Sarnquist C, Holubar M, García-García L, Ferreyra-Reyes L, Delgado-Sánchez G, Cruz-Hervert LP, Montero-Campos R, Altamirano J, Purington N, Boyle S, Modlin J, Ferreira-Guerrero E, Canizales-Quintero S, Díaz Ortega JL, Desai M, Maldonado YA.   +15 more
europepmc   +1 more source

Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016.

Int J Infect Dis, 2021
Ahmad M, Verma H, Kunwar A, Soni S, Sinha U, Gawande M, Sethi R, Nalavade U, Sharma D, Bhatnagar P, Bahl S, Deshpande J.   +11 more
europepmc   +1 more source

Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial. [PDF]

Lancet
Ochoge M, Futa AC, Umesi A, Affleck L, Kotei L, Daffeh B, Saidy-Jah E, Njie A, Oyadiran O, Edem B, Jallow M, Jallow E, Donkor SA, Tritama E, Abid T, Jones KAV, Mainou BA, Konz JO, Fix A, Gast C, Clarke E.   +20 more
europepmc   +1 more source

Oral poliovirus vaccine.

Public health reports (Washington, D.C. : 1896), 1998
openaire   +1 more source

Ending Use of Oral Poliovirus Vaccine - A Difficult Move in the Polio Endgame. [PDF]

N Engl J Med, 2018
Pallansch MA.
europepmc   +1 more source

Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.

Releve epidemiologique hebdomadaire, 2006
openaire   +1 more source

Modeling the Potential Role of Inactivated Poliovirus Vaccine to Manage the Risks of Oral Poliovirus Vaccine Cessation

Journal of Infectious Diseases, 2014
Background: The Global Polio Eradication Initiative plans to stop all oral poliovirus vaccine (OPV) after wild poliovirus eradication, starting with serotype 2.
Kimberly M Thompson, Radboud Duintjer Tebbens, Duintjer Tebbens Radboud J   +2 more
exaly   +3 more sources

Modeling the Dynamics of Oral Poliovirus Vaccine Cessation

Journal of Infectious Diseases, 2014
Background: Oral poliovirus vaccine (OPV) results in an ongoing burden of poliomyelitis due to vaccine-associated paralytic poliomyelitis and circulating vaccine-derived polioviruses (cVDPVs).
Kimberly M Thompson, Radboud Duintjer Tebbens, Duintjer Tebbens Radboud J   +2 more
exaly   +3 more sources

Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study

Lancet, The, 2007
BACKGROUND: A high-potency monovalent oral type 1 poliovirus vaccine (mOPV1) was developed in 2005 to tackle persistent poliovirus transmission in the last remaining infected countries. Our aim was to assess the efficacy of this vaccine in India. METHODS:
Jagadish Deshpande, Nicholas Grassly, Roland W Sutter   +2 more
exaly   +2 more sources